392
Views
20
CrossRef citations to date
0
Altmetric
Research Articles

Defining the design space for freeze-dried orodispersible tablets with meloxicam

, , , , , , , & show all
Pages 1977-1989 | Received 02 Nov 2015, Accepted 06 May 2016, Published online: 01 Jun 2016

References

  • European Pharmacopoeia. Council of Europe. Strasbourg. 8th Edition, Supplement. 2014. Available from: http://online6.edqm.eu/ep800/ [last accessed 4 Mar 2015].
  • U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry Orally Disintegrating Tablets. 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf [last accessed 4 Mar 2015].
  • Ibrahim HK, El-Setouhy DA. Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization. AAPS PharmSciTech 2010;11:189–96.
  • Desai PM, Er PX, Liew CV, Heng PWS. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach. AAPS PharmSciTech 2014;15:1093–104.
  • Swamy PV, Areefulla SH, Shirsand SB, Smitha G. Comparative evaluation of mouth dissolving tablets of meloxicam prepared by sublimation and effervescent techniques. Int J Pharm Sci Bio 2010;1:30–6.
  • Grohganz H, Lee Y, Rantanen J, Yang M. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process. Int J Pharm 2013;447:224–30.
  • Szepes A, Ulrich J, Farkas Z, et al. Freeze-casting technique in the development of solid drug delivery systems. Chem Eng Process 2007;46:230–8.
  • AlHusban F, Perrie Y, Mohammed AR. Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents. Eur J Pharm Biopharm 2010;75:254–62.
  • Kasper JC, Friess W. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur J Pharm Biopharm 2011;78:248–63.
  • Barresi AA, Ghio S, Fissore D, Pisano R. Freeze drying of pharmaceutical excipients close to collapse temperature: influence of the process conditions on process time and product quality. Dry Technol 2009;27:805–16.
  • Turck D, Roth W, Busch U. A review of the clinical pharmacokinetics of meloxicam. Brit J Rheumatol 1996;35:13–6.
  • Han H-K, Choi H-K. Improved absorption of meloxicam via salt formation with ethanolamines. Eur J Pharm Biopharm 2007;65:99–103.
  • Kasper JC, Winter G, Friess W. Recent advances and further challenges in lyophilization. Eur J Pharm Biopharm 2013;85:162–9.
  • Tomba E, Facco P, Bezzo F, Barolo M. Latent variable modeling to assist the implementation of quality-by-design paradigms in pharmaceutical development and manufacturing: a review. Int J Pharm 2013;457:283–97.
  • Rajalahti T, Kvalheim OM. Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm 2011;417:280–90.
  • ALHusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. Eur J Pharm Biopharm 2011;79:627–34.
  • ICH Q8 (R2). Pharmaceutical development. 2009. Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm073507.pdf [last accessed 29 May 2015].
  • Malmö: MKS Umetrics AB. User Guide to MODDE version 10.1, 2014.
  • Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets: an overview. AJP 2010;21:2–11.
  • Chandrasekhar R, Hassan Z, AlHusban F, et al. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm 2009;72:119–29.
  • Rowe R, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th edn. London: Pharmaceutical Press, 2006.
  • Matthews KH, Stevens HNE, Auffret AD, et al. Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier. Int J Pharm 2005;289:51–62.
  • Nassab PR, Rajko R, Szabo-Revesz P. Physicochemical characterization of meloxicam-mannitol binary systems. J Pharm Biomed Anal 2006;41:1191–7.
  • De Beer TRM, Wiggenhorn M, Hawe A, et al. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers. Talanta 2011;83:1623–33.
  • Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21:191–200.
  • Kumar L, Baheti A, Bansal AK. Determination of glass transition of the freeze concentrate for lyophilization using novel ex situ supersaturation technique. Termochim Acta 2013;559:82–5.
  • Kim AI, Akers MJ, Nail SL. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J Pharm Sci 1998;87:931–5.
  • Adesina SK, Wight SA, Akala EO. Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design. Drug Dev Ind Pharm 2014;40:1547–56.
  • Awotwe-Otoo D, Agarabi C, Wu GK, et al. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Int J Pharm 2012;438:167–75.
  • Singh KP, Singh AK, Gupta S, Sinha S. Optimization of Cr (VI) reduction by zero-valent bimetallic nanoparticles using the surface modeling approach. Desalination 2011;270:275–84.
  • Patil H, Feng X, Ye X, et al. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS Pharm Sci Tech 2015;17:194–205.
  • Arik Kibar EA, Us F. Thermal, mechanical and water adsorption properties of corn starch-carboxymethylcellulose/methylcellulose biodegradable films. J Food Eng 2013;114:123–31.
  • Harnkarnsujarit N, Charoenrein S, Roos YH. Microstructure formation of maltodextrin and sugar matrices in freeze-dried systems. Carbohydr Polym 2012;88:734–42.
  • Chung N-O, Lee MK, Lee J. Mechanism of freeze-drying drug nanosuspensions. Int J Pharm 2012;437:42–50.
  • Fukami J, Yonemochi E, Yoshihashi Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101–9.
  • Rajko R, Nassab PR, Szabo-Revesz P. Self-modeling curve resolution method applied for the evaluation of dissolution testing data: a case study of meloxicam-mannitol binary systems. Talanta 2009;79:268–74.
  • Searles JA. Freezing and annealing phenomena in lyophilization. In Rey L, May JC, eds. Freeze drying/Lyophilization of pharmaceutical and biological products. London: Informa Healthcare; 2010:52–76.
  • Webb SD, Cleland JL, Carpenter JF, Randolph TW. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma. J Pharm Sci 2003;92:715–29.
  • Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162–71.
  • Torrado S, Torrado S. Characterization of physical state of mannitol after freeze-drying: effect of acetylsalicylic acid as a second crystalline cosolute. Chem Pharm Bull 2002;50:567–70.
  • ICH Q10. Pharmaceutical quality system. 2008. Available from: http://www.ich.org/fileadmin/Public_ Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf [last accessed 29 May 2015].
  • Zhang L, Yan B, Gong X, et al. Application of quality by design to the process development of botanical drug products: a case study. AAPS PharmSciTech 2013;14:277–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.